Letter to CDC Director Dr. Thomas Frieden Regarding Biolab Safety

June 25, 2012

Excerpt: The Committee on Energy and Commerce is investigating whether the Centers for Disease Control and Prevention (CDC) is complying with Federal safety requirements in its operation of the Emerging Infectious Diseases Laboratory, also known as CDC Building 18, a $214 million Biosafety Level 3 germ lab facility used for experiments involving anthrax, dangerous strains of influenza, the SARS coronavirus, monkeypox and other microbes with bioweapons potential

To read the letter, click here.

To read a related press release, click here.

Letter Type: